you'll have more options to help patients get a suitable atypical antipsychotic

The approval of Latuda (lurasidone) means you'll have more options to help patients get a suitable atypical antipsychotic.

More money is spent on antipsychotics than any other class.

That's because these drugs are being used more for bipolar disorder, depression, autism, etc. Plus most cost $15 to $20 per day.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: MD includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote